The cost-utility of stepped-care algorithms according to depression guideline recommendations - Results of a state-transition model analysis.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Meeuwissen, Jolanda A CFeenstra, Talitha L
Smit, Filip
Blankers, Matthijs
Spijker, Jan
Bockting, Claudi L H
van Balkom, Anton J L M
Buskens, Erik
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
The cost-utility of stepped-care algorithms according to depression guideline recommendations - Results of a state-transition model analysis.Published in
Journal Affect Disord 2019; 242(1):244-54Publiekssamenvatting
Evidence-based clinical guidelines for major depressive disorder (MDD) recommend stepped-care strategies for sequencing evidence-based treatments conditional on treatment outcomes. This study aims to evaluate the cost-effectiveness of stepped care as recommended by the multidisciplinary clinical guideline vis-à-vis usual care in the Netherlands.PMID
30216769ae974a485f413a2113503eed53cd6c53
10.1016/j.jad.2018.08.024
Scopus Count
Collections
Related articles
- Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial.
- Authors: van der Aa HPA, van Rens GHMB, Bosmans JE, Comijs HC, van Nispen RMA
- Issue date: 2017 Aug 1
- Cost-effectiveness of guideline-based stepped and collaborative care versus treatment as usual for patients with depression - a cluster-randomized trial.
- Authors: Brettschneider C, Heddaeus D, Steinmann M, Härter M, Watzke B, König HH
- Issue date: 2020 Aug 28
- Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
- Authors: Health Quality Ontario
- Issue date: 2016
- Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
- Authors: Snedecor SJ, Botteman MF, Schaefer K, Sarocco P, Barry N, Pickard AS
- Issue date: 2010 Mar
- Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
- Authors: Simpson KN, Welch MJ, Kozel FA, Demitrack MA, Nahas Z
- Issue date: 2009 Mar